MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Fraud Lawsuit

Stock Information for Metagenomi Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Metagenomi Inc.

Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025
Metagenomi Reports Business Updates and First Quarter 2025 Financial Results
Metagenomi to Present at Upcoming Scientific Meetings
Metagenomi Reports Business Updates and Full Year 2024 Financial Results
Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems
Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference
Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer
Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.